Galera Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.0663 | -268.1 | -99.98% | -1.66 | -96.01% |
| P/S |
|
0 | 55.96 | -100% |
|
|
| P/BV |
|
-0.0174 | 251.23 | -100.01% |
|
|
| P/FCF |
|
-0.1035 | -196.64 | -99.95% |
|
|
| Ev/Ebitda |
|
0.287 | 12.23 | -97.65% |
|
|
| Ev/S |
|
0 | 457.86 | -100% |
|
|
| Ev/FCF |
|
0.4765 | -232.19 | -100.21% |
|
|
| E/P |
|
-15.09 | 0.0224 | -67573.51% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -341.3 | -100% | 0 | 0% |
| ROE |
|
13.79 | 103.63 | -86.69% |
|
|
| ROA |
|
-104.61 | -2.84 | 3586.08% |
|
|
| ROIC |
|
0 | 1.17 | -100% |
|
|
| ROS |
|
0 | -298.77 | -100% |
|
|
| ROCE |
|
32.68 | -0.0718 | -45615.58% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-7.55 | 0.9431 | -901.02% | -2.17 | +248.2% |
| Nеt Debt/Ebitda |
|
0.4112 | 1.03 | -59.89% |
|
|
| Debt/Ratio |
|
15.08 | 0.1785 | 8345.64% |
|
|
| Debt/Equity |
|
-1.07 | 1.56 | -168.83% |
|
|
| Debt/Net Income |
|
-8.03 | -1.48 | 442.77% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8444 | -100% | ||
| DSI |
|
0 | 0.2147 | -100% |
|
|
| Average dividend growth |
|
0 | 1.27 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5087 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.63 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -87.95 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-71.44 | -156.19 | -54.26% | ||
| Growth impulse Net Income in 5 years |
|
-74.45 | -172.49 | -56.84% | ||
| Growth impulse FCF in 5 years |
|
-79.76 | -114.74 | -30.49% | ||
| Growth impulse EPS in 5 years |
|
-88.36 | -98.04 | -9.87% |
IP Score
2.78/10
